GLAXO

GlaxoSmithKline Pharmaceuticals Limited

IN Healthcare Drug Manufacturers - General

Latest week
10 Jul 2026
Close
2438.199951
Fair value
2352.753446
Next-week expectancy
Undecided 48.29%
Sharemaestro

GLAXO Chart Pack

GlaxoSmithKline Pharmaceuticals Limited

Exchange
NSI
Latest week
10 Jul 2026
Close
2438.199951
Fair value
2352.753446
Next-week expectancy
Undecided 48.29%
Generated
17 Jul 2026 00:39
Sector
Healthcare
Industry
Drug Manufacturers - General

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, GLAXO rose 1.14%, moving from 2,410.64 to 2,438.20. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -1.32 and has improved across the 12-week window. Market Dynamics is 0.88 on the latest week. Next-week expectancy is undecided at 48.29% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
2,438.20
12-Week Change
1.14%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 48.29%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-1.32
Market Dynamics
0.88

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
2,438.20
12-Week Change
1.14%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 48.29%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-1.32
Market Dynamics
0.88

Over the latest 12 completed weeks ending 2026-07-10, GLAXO rose 1.14%, moving from 2,410.64 to 2,438.20. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -1.32 and has improved across the 12-week window. Market Dynamics is 0.88 on the latest week. Next-week expectancy is undecided at 48.29% based on similar historical setup states.

Industry Peers

India equities in Drug Manufacturers - General

Stock Exchange Week Open High Low Close Change
RUBICON RUBICON RESEARCH LIMITED NSI 10 Jul 2026 1330.50 1439.00 1320.00 1431.40 7.58%
PFIZER Pfizer Limited NSI 10 Jul 2026 4570.00 4747.80 4503.40 4731.40 3.53%
MARKSANS Marksans Pharma Limited NSI 10 Jul 2026 264.00 281.60 257.50 272.40 3.18%
SENORES SENORES PHARMACEUTICALS L NSI 10 Jul 2026 1389.90 1487.90 1313.60 1417.80 2.01%
KOPRAN Kopran Limited NSI 10 Jul 2026 195.99 198.00 179.93 196.82 0.42%
TTKHLTCARE TTK Healthcare Limited NSI 10 Jul 2026 923.10 942.45 880.60 920.40 -0.29%
SANOFI Sanofi India Limited NSI 10 Jul 2026 3425.00 3488.90 3340.00 3401.90 -0.67%
SANOFICONR SANOFI CONS HEALTHC IND L NSI 10 Jul 2026 4602.90 4726.00 4500.30 4566.70 -0.79%
NGLFINE NGL Fine-Chem Limited NSI 10 Jul 2026 3230.00 3329.00 3027.10 3193.60 -1.13%
SMSPHARMA SMS Pharmaceuticals Limited NSI 10 Jul 2026 423.30 435.00 398.25 402.70 -4.87%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.